Elsie Koh, MD
Vascular & Interventional Radiology · Woodland Park, NJNPI 1679548234
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (51.5%), royalties or licence payments and education — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 64.0% of it on its own, with 25 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $771.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$96K
- Medtronic$35K
- Avenu Medical Inc.$8K
- Fresenius USA Marketing, Inc.$4K
- Terumo Medical Corporation$1K
- Bard Peripheral Vascular, Inc.$1K
- plus $5K from 20 others
Across 3 payments — averaging $16,667 each. An ownership or investment interest held by the physician or an immediate family member.
- Vasorum USA Inc.$50K
What the payments were for
- Royalty or licence$31,93321%
- Consulting fees$6,9005%
- Speaking & faculty fees$1,7491%
- Travel & lodging$5,6744%
- Food & beverage$8,0175%
- Education$17,87512%
- Gifts$4750%
- Other$77,08351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 21 | $95,786 |
| Medtronic(2 entities) | 46 | $34,680 |
| Avenu Medical Inc. | 16 | $8,207 |
| Fresenius USA Marketing, Inc. | 9 | $3,861 |
| Terumo Medical Corporation | 13 | $1,139 |
| Bard Peripheral Vascular, Inc. | 15 | $1,119 |
| Fresenius USA Inc. | 2 | $1,000 |
| Cardiovascular Systems Inc. | 31 | $874 |
| Philips North America LLC | 3 | $555 |
| Globus Medical | 7 | $555 |
| Shockwave Medical, Inc | 2 | $400 |
| Boston Scientific | 2 | $315 |
| Johnson & Johnson | 7 | $232 |
| Cordis US CORP. | 1 | $178 |
| Veryan Medical Incorporated | 2 | $139 |
| 4web, Inc. | 1 | $119 |
| Nevro Corp. | 1 | $118 |
| Vasorum USA Inc. | 2 | $97 |
| Covidien LP | 1 | $62 |
| Tactile Systems Technology Inc | 2 | $58 |
| Advanced Oxygen Therapy Inc. | 2 | $47 |
| Cardinal Health 200 LLC | 2 | $46 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Biotronik Inc. | 2 | $31 |
| Abbott | 1 | $30 |
| Smith+Nephew | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$92,263
- VenaSeal$30,933
- Ellipsys$7,560
- Auryon$2,875
- TurboHawk$1,076
- TR Band$863
- VENOVO$707
- (9520) IGT Devices Undivided$534
- INCEPTIV$513
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$400
- INTELLIS ADAPTIVESTIM$354
- AngioVac$350
- Ellipsys System$306
- Senza$300
- HawkOne$215
- SABER$178
- GENERAL EMBOLICS$168
- Peripheral Orbital Atherectomy System$168
- TRUSELECT$147
- Abre$126
How this compares
$149,706 in reported general payments places this provider in the 90th percentile of 111 vascular & interventional radiology providers in New Jersey.
See all vascular & interventional radiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 108 | $63,474 |
| ClopidogrelClopidogrel Bisulfate | 42 | $224 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $232 | $63,474108 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 111 vascular & interventional radiology providers in New Jersey.
Other vascular & interventional radiology in Woodland Park
- John RundbackTeaneck$507K
- Nicholas PetruzziGalloway$407K
- Sabina AminCamden$346K
- Israel SchurClifton$247K
- Micah WattsGalloway$225K
- Kevin HermanTeaneck$154K
- Daniel BurrittVineland$112K
- Vincent GalloTeaneck$96K
- Daniel SimonNew Brunswick$43K
- Waseem BhattiSummit$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.